Meiling Chen

Fujian Provincial Key Laboratory On Hematology, Fujian Medical University Union Hospital
Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Real-World Delivery, Dose Adaptation, and Molecular Monitoring of Gilteritinib, Venetoclax, and Azacitidine in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia.

Real-World Delivery, Dose Adaptation, and Molecular Monitoring of Gilteritinib, Venetoclax, and Azacitidine in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 22, 2026

Unravelling the nexus of non-coding RNAs in cancer stemness and therapeutic drug resistance.

Unravelling the nexus of non-coding RNAs in cancer stemness and therapeutic drug resistance.

Journal: Frontiers in cell and developmental biology

Published: April 30, 2026

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

Journal: Cancer discovery

Published: July 19, 2024

CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.

CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.

Journal: Theranostics

Published: June 29, 2024

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.

Journal: Cell

Published: November 18, 2023

Title Not Found

Title Not Found

Journal: Clinical and translational medicine

Published: November 05, 2023

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Journal: Cell reports. Medicine

Published: October 31, 2023

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer.

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer.

Journal: Frontiers in oncology

Published: September 23, 2022

METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.

METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.

Journal: Cell stem cell

Published: January 11, 2022

Acute myeloid leukemia in an 86-year-old man with AML1/ETO treated with Homoharringtonine and Arsenic Trioxide: A case report.

Acute myeloid leukemia in an 86-year-old man with AML1/ETO treated with Homoharringtonine and Arsenic Trioxide: A case report.

Journal: Medicine

Published: March 29, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026